The 8th Annual Frontiers in Diabetes Research Symposium of 2024 upheld the successful thematic approach initiated last year. This year's symposium spotlighted research particularly focusing on 'Islet Transplantation'. A primary objective of SDRC is to amplify the diverse expertise and leadership within our research cohorts. With approximately 100 enthusiastic attendees, the symposium sparked dynamic discussions that are poised to catalyze future collaborative ventures among SDRC members. Spanning across Stanford University, UC Berkeley, and UC Davis, SDRC boasts a membership of 125 individuals. The symposium provided a platform for trainees from member labs to showcase their research through scientific posters and presentations. A new addition this year was the introduction of Lightning Talks, enabling trainees to succinctly present their work in 60-second elevator pitches, followed by engaging poster sessions. The poster session garnered significant participation. Herein, we recognize exceptional trainees who received accolades for presenting their research work in the categories of best poster, best lightning talk, and runner-up prizes:

1. Stephan Ramos – Best Research Poster Award for his work titled "Advancing cell-based therapies for diabetes through optimized bone marrow conditioning and hematopoietic chimerism"

2. Saranya Raghupaty– Runner-Up Research Poster Award for her work titled "A novel liver-derived peptide that controls appetite and energy expenditure "

3. Seth Sharp – Runner-Up Research Poster Award for his work titled " Integration of islet multi-omics with a “GWAS-in-a-Dish” identifies cellular regulators of glucose stimulated insulin secretion and insulin content"

4. Aimee Bastidas-Ponce– Best Lightening Talk Award for her work titled “Investigating novel determinants of pancreatic beta cell development using a novel genetic mouse model of neonatal diabetes (NDM)”.

Two distinguished keynote speakers graced our event. Dr. James Shapiro enlightened us on the history of diabetes and islet transplantation, while Dr. Melina Bellin shared insights from their acclaimed islet auto-transplant program, highlighting valuable lessons. Guided by Dr. Kent Jensen, Assistant Director of DIMC, a thought-provoking panel discussion ensued, exploring the question: "Is the future of Diabetes Treatment rooted in Islet transplantation, cell replacement, or technological advancements?" This engaging session convened medical professionals, researchers, and individuals with diabetes to deliberate on the promising trajectory of diabetes treatment through islet transplantation.

Click here for agenda

Archives

2023 2022 2019 2018
2017
2016